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Abstract
Hydroxyapatite (HAP)-containing poly-ε-caprolactone (PCL)–polydiisopropyl fumarate (PDIPF)
composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical,
mechanical and biocompatibility properties of these composites were evaluated using two
osteoblast-like cell lines (UMR106 and MC3T3E1) and compared with the blend without HAP
and PCL/HAP films. The increment in the elastic modulus and the decrease in the elongation-
at-break of Blend–HAP suggest that the mechanical properties of the HAP scaffolds have
improved significantly. The addition of HAP to both PCL and Blend significantly improves the
cell biocompatibility and osteogenicity of the scaffolds. Evidence for this notion is based in several
observations: (a) HAP–polymer increases proliferation of osteoblastic cells; (b) HAP included in the
blend increases the ALP expression in UMR106 cells; (c) HAP–Blend increases the type-I collagen
production in both cell lines, and d) higher levels of the osteogenic transcription factor Runx-2 were
detected when MC3T3E1 osteoblasts were induced to differentiate and mineralize on HAP–polymer
scaffolds. In conclusion, a novel biocompatible HAP–Blend composite with uniform dispersion of
semi-nano HAP particles and good interphase compatibility has been prepared successfully. The
development of HAP–Blend composite, with improved physical, mechanical and osteoinductive
properties, may potentially be used in bone tissue-engineering applications. Copyright  2011 John
Wiley & Sons, Ltd.
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1. Introduction
Tissue-engineering strategies have led to the development
of artificial scaffolds, which can simulate biological
extracellular matrix, supporting adhesion, proliferation,
differentiation and tissue regeneration (Mano et al.,
2007). Different synthetic or natural polymers have
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been used to fabricate matrix for bone regeneration,
such as polyesters (polyglycolide, polylactides) and poly-
ε-caprolactones and their copolymers (Habibovic and
de Groot, 2007). These materials are characteristically
hydrolytically degradable and biocompatible, although
they do not show good mechanical properties. Thus,
no single polymer has been found to meet all the
requirements needed for a bone scaffold.
In previous studies, we have used polyester (poly-β-
propiolactone, PBPL; poly-ε-caprolactone, PCL) and poly-
fumarate (polydiisopropyl fumarate, PDIPF; polydicyclo-
hexyl fumarate, PDCF) mixtures to create scaffolds which
support in vitro osteoblastic development (Cortizo et al.,
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2008). Our studies have shown that polyester–PDIPF
matrices (Cortizo et al., 2008) as well as PCL–PDIPF
blends (Fernandez et al., 2010) support adhesion, pro-
liferation and differentiation of UMR106 and MC3T3E1
osteoblastic cell lines without evidence of cytotoxicity. In
addition we investigated the degradation capabilities of
the different films. Under acellular conditions, only PBPL
was hydrolytically degraded. However, macrophages cul-
tured on PDIPF films demonstrated a significant degra-
dation of polymers, indicating that polyfumarates as well
as polyesters can be degraded by cellular mechanisms
(Cortizo et al., 2008).
The mechanical properties of polymeric materials can
be improved by the addition of calcium phosphate
bioceramics. For instance, hydroxyapatite (HAP) and
tricalcium phosphate have been widely used to create
composite scaffolds for bone tissue regeneration (Kim
et al., 2006;Wang, 2003). The inclusion of thesematerials
in polymeric scaffolds makes them more brittle, limited
for modelling and with a longer degradation rate (Wang,
2003). The idea is to find a material that can be modelled
and can simulate the mechanical and biological properties
of an implant. In actual fact, bone tissue is a composite of
nano-hydroxyapatite crystals immersed in a collagen and
non-collagen protein matrix.
One important step in the development of scaffolds for
tissue engineering is to evaluate the biocompatibility and
cytotoxicity of the materials (Salgado et al., 2004). These
studies are based on the morphological and biochemical
changes of cells, growth and cell differentiation. The
success of the construct will depend on the ability of
the scaffold to induce the development of osteoblast
and bone transcription factors outside of the body or by
stimulating cells tomigrate into the implant. In the present
study, we fabricated HAP–PCL and HAP–PCL–PDIPF
composite scaffolds through a simple solution-based
chemical method which provides a very good dispersion
of HAP particles in the matrix polymer, yielding a
composite with an uniform structure. We have analysed
the physicochemical, mechanical and biocompatibility
properties of these composites for future applications in
bone tissue engineering.
2. Materials and methods
2.1. Synthesis and characterization of
composite scaffolds
Poly-ε-caprolactone (PCL) was purchased from Aldrich
and has a weight average molecular weight (MW) and
polydispersity index of 65 000 g/M and 1.4, respec-
tively, as indicated by the manufacturer. Poly(di-
isopropylfumarate) (PDIPF) was synthesized by
microwave-assisted radical polymerization, using
benzoyl peroxide as the initiator (Cortizo, 2007). The
weight averagemolecular weight and polydispersity index
were 131 000 g/M and 2.0, respectively, determined by
size exclusion chromatography (SEC).
Compatibilized blends of PCL and PDIPF (75:25 wt%;
Blend) were obtained by ultrasound using Bandelin HD60
equipment at 20 ◦C, as previously described (Fernandez
et al., 2010).
Hydroxyapatite (HAP) was obtained as follows. Adult
bovine femur was procured from a local slaughterhouse
and cleaned to remove visible soft tissues on the bone
surface. It was then cut into small samples. The samples
were first incinerated with a burner and then with an
electric furnace (in order to eliminate organic materials),
under normal atmosphere conditions, at 900 ◦C, using
a heating rate of 5 ◦C/min with 2 h holding time (Ooi
et al., 2007). The ashes were crushed and sifted (number
200, pore size 75 µm) and subsequently processed by
ultrasound until a size of approximately 200 nm was
attained.
Composites of 1 wt% HAP and PCL or Blend were
obtained by dissolution in chloroform and casting in a
glass Petri dish. The solvent was allowed to evaporate
at room temperature and then the resulting films were
dried under vacuum until constant weight. The films were
sterilized by UV exposure for 2 h (Fernandez et al., 2010).
The weight average molecular and molecular weight
distribution of the polymers were determined by size
exclusion chromatography, using an LKB-2249 instrument
at 25 ◦C. A series of µ-Styragel columns, pore sizes 105,
104, 500 and 100 A˚, were used with chloroform as an
eluent. The polymer concentration was 4–5 mg/ml and
the flow rate was 0.5 ml/min. The polymer was detected
at 5.75 µm with a Miran 1A infrared spectrophotometer
detector and calibration was performed using poly(methyl
methacrylate) as standard.
The surface roughness of the HAP and of the
composites was investigated using scanning electron
microscopy (SEM; Phillips 505, The Netherlands), with an
accelerating voltage of 20 kV. The images were analysed
by Soft Imaging System ADDAII. In addition, Ca:P ratio of
the HAP was evaluated by SEM coupled with an energy-
dispersive X-ray (EDX) analysis detector.
FTIR spectra of HAP and Blend–HAP were recorded
on a Nicolet 380 FTIR between 4000–400 cm−1 with
a resolution of 4 cm−1 and 32 scans of accumulation.
EZ-OMNIC software was used to analyse the spectra.
The tensile properties of the composites were deter-
mined with a universal testing machine (Digimess
TC500), using force load cell (‘Interface’ of Arizona, USA),
SM-50 N capacity, at room temperature. The dog bone-
shaped specimens (50 × 18 mm2) were tested at a rate
of 5 mm/min until breaking point. Ultimate tensile stress,
elastic modulus and elongation at breaking point were cal-
culated on the basis of the generated tensile stress–strain
curves. The results presented are the mean values of eight
independent measurements.
HAP particle distribution within the films was inves-
tigated by staining with alizarin red S. Images were
recorded using an Eclipse E400 Nikon microscope and
a Nikon Coolpix 4500 digital camera.
Copyright  2011 John Wiley & Sons, Ltd. J Tissue Eng Regen Med (2011).
DOI: 10.1002/term
Osteoconductive PCL–PDIPF–hydroxyapatite composite scaffold for bone TE
2.2. Biocompatibility studies
2.2.1. Cell cultures and incubations
UMR106 rat osteosarcoma cells or MC3T3E1 mouse
calvaria-derived cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% FBS, 100
U/ml penicillin and 100 µg/ml streptomycin at 37 ◦C
in a 5% CO2 atmosphere (McCarthy et al., 1997). The
cells were seeded in standard tissue culture flasks and
subcultured using trypsin–EDTA. The UMR106 cell line
has been shown to conserve certain characteristics of
differentiated osteoblastic phenotype (Partridge et al.,
1983). In the case of non-transformed MC3T3E1 cells,
previous studies have demonstrated that expression of
osteoblastic markers begins after culturing the cells with
medium supplemented by 5 mM β-glycerol-phosphate
(βGP) and 25 µg/ml ascorbic acid (AA) (Quarles
et al., 1992). Under these culture conditions, alkaline
phosphatase activity (ALP) begins to be expressed after
1 week and reaches a maximum after 2 weeks, while
mineralization is achieved after extending the culture
to 3 weeks. However, the cells only undergo active
replication during the first 5 days of incubation. For
the different experiments, 0.8 mm diameter composite
scaffolds were placed in 24-well plates and sterilized by
UV. Then the cells were seeded onto 10% FBS–DMEM-
presoaked scaffolds and incubated during the periods of
time indicated in the legends to the figures.
2.2.2. Evaluation of osteoblastic growth and
differentiation
The ability of osteoblastic cells to grow and express
markers of differentiation associated with bone-forming
capacity was evaluated by measurement of the number
of cells stained with haematoxylin and eosin (H&E 48 h
culture), alkaline phosphatase (ALP) activity and collagen
production (Fernandez et al., 2010; Cortizo et al., 2006).
Briefly, cells were fixed with methanol for 5 min and then
stained with H&E for 10 min, after which cell proliferation
was evaluated by counting the number of cells/field in 10
fields per experimental condition. For ALP determination,
cells were washed with phosphate-buffered saline (PBS)
and solubilized in 0.5 ml 0.1% Triton X-100. Aliquots of
this total cell extract were used for protein determination
by the Bradford (1976) technique, and for measurement
of ALP by spectrophotometric determination of initial
rates of hydrolysis of p-nitrophenyl-phosphate (p-NPP)
to p-nitrophenol (p-NP) at 37 ◦C for 10 min. For type I
collagen production, cells were fixed with Bouin’s solution
and stained with Sirius red dye for 1 h. The stained
material was dissolved in 1 ml 0.1 N sodium hydroxide
and the absorbance of the solution was recorded at
550 nm (Tullberg-Reinert and Jundt, 1999).
2.3. Transcription factor Runx and Osteocalcin
expression by western blot analysis
MC3T3E1 were grown for different incubation periods
onto scaffolds in DMEM–10% FBS and then differentiated
into osteoblasts as described above. At the end of
different culture periods, cells were lysed in Laemmli’s
buffer (Laemmli, 1970). These lysates were heated to
100 ◦C for 3 min, and 30 µg protein subjected to 12%
SDS–PAGE. The separated proteins were then transferred
to PVDF membranes. After washing and blocking, the
membranes were incubated overnight at 4 ◦C with an
antibody directed against Cbfa-1/Runx-2 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) for evaluation of
osteoblastogenesis (Molinuevo et al., 2010). In order
to normalize the results, all blots were stripped and
reprobed with an anti-β-actin antibody (Sigma, St.
Louis, MO, USA). Blots were developed by an enhanced
chemiluminescence method. The intensity of the specific
bands was quantified by densitometry after scanning of
the photographic film. Images were analysed using the
Scion-β2 program.
2.4. Statistical analysis
Results are expressed as the mean ± SEM and, unless
indicated otherwise, were obtained from two separate
experiments performed in triplicate. Differences between
the groups were assessed by one-way ANOVA with Tukey
post hoc test. For non-Normal distributed data, non-
parametrical Kruskal–Wallis with Dunn post hoc test was
performed, using GraphPad InStat v. 3.00 (Graph Pad
Software, San Diego, CA, USA). p < 0.05 was considered
significant for all statistical analyses.
3. Results
3.1. Characterization of HAP, PCL–HAP and
Blend–HAP composite scaffolds
Since a composite material consists of at least two
chemically different phases, its properties are strongly
influenced by a number of factors. One of the most
important is the integration of the two phases, which
depends on the filler size and size distribution. In
order to characterize the morphology and chemical
composition of HAP, SEM–EDX imaging was used.
Figure 1A shows that the particles exhibited an irregular
form. The analysis of particle sizes indicates that the
HAP average size was 225 ± 4 nm, a semi-nano range
with a narrow size distribution, allowing homogeneous
distribution into the composites. It should be noted that
previous to ultrasonic treatment, the HAP particle size
was 48.6 ± 2 µm, indicating the efficiency of the applied
methodology in reducing the particle size. The Ca:P molar
ratio (1.67; Figure 1B) was similar to that of cortical bone
mineral previously reported (1.64) (Kuhn et al., 2008).
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Figure 1. SEM (A), EDX spectra (B), FTIR analysis (C) for HAP, and FTIR of Blend–HAP (D)
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Figure 2. SEM images of the surface of PCL (A), PCL–HAP (B), Blend (C) and Blend–HAP (D)
A
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B
Figure 3. Distribution of HAP in the scaffolds. PCL (A), PCL–HAP (B), Blend (C) and Blend–HAP (D) films were stained with alizarin
red S to demonstrate the presence of Ca in HAP incorporated in the films. Original magnification, ×40
Copyright  2011 John Wiley & Sons, Ltd. J Tissue Eng Regen Med (2011).
DOI: 10.1002/term
J. M. Fernandez et al.
A
C
E
G
F
D
H
B
Figure 4. UMR106 (A–D) and MC3T3E1 (E–H) cells growing on different scaffolds. Cells were plated onto PCL (A, E), PCL–HAP (B,
F), Blend (C, G) and Blend–HAP (D, H) and cultured for 24 h. After this incubation period the cells were fixed and stained with
Giemsa. Original magnification, ×40
The C:P molar ratio (0.03) suggests a few carbonate
impurities (1.25g carbonate %HAP). Figure 1C shows the
FTIR spectrum of HAP. The bands at 3572, 3409 and
632 cm−1 correspond to the structural OH groups (free
and associated) in the HAP crystals (Joschek et al., 2000;
Walters et al., 1990). The bands at 1090, 1047, 602
and 570 cm−1 indicate the presence of a PO43− group.
In addition, it shows bands at 1456 and 1412 cm−1,
corresponding to a CO32− component, as shown by EDX
analysis. In Blend–HAP (Figure 1D), which contains 1%
HAP, characteristic bands of PCL and PFIP were observed,
1723 cm−1 (ν C O), 1172 cm−1 (ν C-O), 1470 and
1415 cm−1 (ν CH2). The first two bands appear to be
broader in Blend–HAP than that in Blend alone (data not
shown), probably accounting for crystallinity changes. An
association between HAP and polymers was suggested by
observation of the shift in the bands at 1047, 602 and
570 cm−1 to 1044, 599 and 582 cm−1, respectively.
Figure 2 shows the microstructure of PCL, PCL–HAP,
compatibilized blend, and Blend–HAP. The scaffolds
show the typical spherulite-like morphology similar to
that previously described for pure PCL. The addition
of a small percentage of HAP into the matrix induced
a small decrease in the spherulite size. This was also
associated with an increased surface roughness for the
polymer–HAP.
We also used the alizarin red S staining to observe
the aspect and apatite distribution in the films. Figure 3
show homogeneous and fine HAP particle distribution in
the PCL–HAP matrix, with patched and stronger-staining
HAP particles in the Blend. No staining was found in the
control PCL and Blend films.
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Table 1. Mechanical properties of PCL and compatibi-
lized PCL–PDIPF blends with or without HAP scaffolds
Scaffold Elastic Ultimate Elongation
modulus tensile at breaking
(MPa) stress (MPa) point (%)
PCL 161± 16 15.2± 1.7∗∗ 366± 96∗∗
PCL–HAP 249± 12∗ 16.5± 0.5∗∗ 210± 21
Blend 143± 12 7.7± 0.7 60± 12
Blend–HAP 182± 6# 7.4± 0.7 20± 1#
Results are expressed as mean ± SEM, n = 8.
∗p < 0.05, statistically different from all other groups.
∗∗p < 0.001, statistically different compared with Blend and
Blend–HAP.
#p < 0.05, statistically different from Blend.
Table 1 shows mechanical properties evaluated for the
different scaffolds. The addition of HAP affected the
resistance of the PCL and Blend matrices, as evaluated by
the elastic modulus. The observed moduli of PCL–HAP
and Blend–HAP represent increments of 55% and 27%,
respectively, compared to scaffolds without HAP. No
changes were observed in the ultimate tensile stress by
the addition of apatite to the matrices. However, HAP
induced a decrease in the elongation-at-break of PCL
(43%) and Blend (67%), a measurement of the ductility
of a material. All together these observations suggest
that the mechanical properties of the HAP scaffolds were
improved significantly.
3.2. Biocompatibility studies
In order to investigate the effect of the addition of HAP
on the biocompatibility of scaffolds, two osteoblastic lines
were used to study proliferation and differentiation on
different matrices. Figure 4 shows the aspect of the
UMR106 (A–D) and MC3T3E1 (E–H) cells growing
on different scaffolds for 24 h. In general the cells
adhered and proliferated well, developing extensions
and spreading on all matrices. However, the addition
of 1% HAP in the PCL and Blend increased cell
proliferation. These observations were further confirmed
by quantification of the number of growing cells after
24 h, and are presented in Figure 5A (UMR106) and 5B
(MC3T3E1). It was also observed, as we have previously
described (Fernandez et al., 2010), that UMR106 but not
MC3T3E1 cells proliferated better in the blend when
compared with the PCL film (Figure 5A). Nevertheless,
both cell lines seemed to prefer the polymer–HAP
scaffolds.
We also evaluated the capacity of cells growing on
different matrices to express two markers of bone
formation. Figure 6A, C shows the expression of ALP
after culturing osteoblasts for 48 h (UMR106) or 2 weeks
(MC3T3E1). In the case of the osteosarcoma line
(Figure 6A), the addition of HAP induced a slight
increase in ALP expression. In contrast, the apatite
significantly inhibited ALP expression when MC3T3E1
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Figure 5. UMR106 (A) and MC3T3E1 (B) proliferation after 24 h
culture on PCL, PCL–HAP, Blend or Blend–HAP. Quantitation
was assessed by counting the number of cells per field in 10
representative fields per scaffold. Values are shown as mean ±
SEM. ∗p < 0.05 vs. scaffold without HAP; #p < 0.05 vs. PCL
cells (Figure 6C) were induced to differentiate in an
osteogenic medium for 2 weeks. The production of type I
collagen, the main extracellular matrix protein expressed
in bone, was also evaluated. As can be seen in Figure 6B,
HAP significantly increased the production of collagen
in both types of scaffold, the PCL and the Blend. When
MC3T3E1 cells were cultured for 2 weeks in an osteogenic
medium, the addition of HAP only stimulated collagen
production in the Blend (Figure 6D).
3.3. Effects of scaffolds on osteoblastic
transcription factor Runx2
We next evaluated the effect of different matrices
on the expression of one of the major transcription
factors for osteoblastogenesis, Cbfa1/Runx2. MC3T3E1
cells growing on different scaffolds were cultured in an
osteogenic medium for 3 weeks. Western immunoblot
analysis showed that when compared with cells cultured
in PCL or Blend, MC3T3E1 in the polymer–HAP scaffolds
expressed significantly more Runx2 (Figure 7).
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Figure 6. Effect of the scaffolds on the expression of osteoblastic markers. UMR106 (A, B) and MC3T3E1 (C, D) were cultured on
different scaffolds for 48 h or 2 weeks, respectively. ALP (A, D) and type-I collagen production (B, D) were evaluated as described
in Materials and methods. Values are shown as mean ± SEM. ∗p < 0.05 vs. all other groups; #p < 0.05 vs. Blend
4. Discussion
Wehave previously shown that ultrasound-compatibilized
PCL–PDIPF blends exhibit better biocompatibility with
UMR106 and MC3T3E1 osteoblastic cells than homopoly-
mers (PCL and PDIPF) and the physical blend (Fernandez
et al., 2010). It has been recognized that scaffolds that
will act as temporary matrices for cell proliferation and
extracellular matrix deposition, with consequent bone
in-growth until the new tissue is totally restored or regen-
erated, must have a series of essential properties (Salgado
et al., 2004). In addition to biocompatibility, porosity and
osteoinductivity in order to promote cellular adhesion and
growth, is also crucial that these materials have mechani-
cal properties similar to native bone. To achieve this goal,
different polymer–HAP composites have been studied,
and improved mechanical properties have been demon-
strated. The present study describes the design of a new
scaffold for bone tissue engineering based on compatibi-
lized PCL–PDIPF blends which incorporate HAP in order
to enhance their properties.
Our results demonstrate that the irregular form of the
obtained HAP interacted adequately with the polymer
because, as has been indicated, it forms a mechanical
interlock with the particle (Sˇupova´, 2009). In relation to
the particle size of HAP, some investigators have shown
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Figure 7. Effect of the scaffolds on the expression of Runx-2
in MC3T3E1 cells. Cells were plated on different scaffolds and
cultured in an osteogenic medium for 2 weeks. The expression
of Runx-2 and actin was evaluated by western immunoblot. The
blots were quantified using the Scion-β2 image program and
the corresponding values are shown as bar graphs. Values are
expressed as mean ± SEM
a significant increase in cell adhesion and proliferation
in nano-sized HAP (<100 nm) as a component of
HAP–polymer composites (Webster et al., 2000; Li et al.,
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2009). It has been shown that nano-HAP crystals, due
to their surface characteristics, have a stronger capability
to absorb certain proteins that promote cell adhesion.
Although our HAP has a size in the nm range (225 nm),
its morphology and good interphase compatibility in the
composite (evaluated by FTIR) suggest promissory results.
Another important aspect we have considered is the
distribution of HAP inside the composite. Alizarin red
staining shown an appropriate distribution of particles
which ensures that the composite exhibits isotropic
properties.
Important requirements for scaffold materials are their
mechanical properties, considering that as temporary
bone substitutes they must encourage repair by providing
mechanical support until the tissue is regenerated and
remodelling occurs naturally (Prabhakaran et al., 2009).
Our results show that the HAP–polymer composites
exhibit an increase in the elastic modulus in comparison
to polymer (PCL or blend), which demonstrates that
HAP inclusion improves their mechanical properties. The
ultimate tensile stress of HAP–Blend composite was very
similar to that of mouse femur (about 10 MP) (Ding
et al., 2010), showing significant differences with respect
to PCL–HAP. The decrease in the elongation-at-break
induced by HAP on PCL and Blend suggests that the
obtained composite is less ductile. Both the higher elastic
modulus and lower strain at failure of HAP–polymer
composite can be explained by the stiffness and plasticity
in deformation produced by the HAP mineral, which is
typical of hard inorganic phases.
In the present study we have evaluated different param-
eters in order to assess the biocompatibility/cytotoxicity
of the scaffolds for two osteoblastic lines. We have found
that the addition of HAP to both PCL and Blend signif-
icantly improves the biocompatibility and osteogenicity
of the scaffolds. Evidence for this notion is based in
several observations: (a) HAP–polymer increases pro-
liferation of osteoblastic cells; (b) HAP included in
the blend increases ALP expression in UMR106 cells;
(c) HAP–Blend increases the type I collagen production
in both cell lines; and (d) higher levels of the osteogenic
transcription factor Runx-2were detectedwhenMC3T3E1
osteoblasts were induced to differentiate and mineralize
on HAP–polymer scaffolds. These observations indicate
that the incorporation of hydroxyapatite increases the
in vitro osteogenicity of PCL and Blend films.
Previously we have developed a compatibilized blend
that was able to support the growth and differentiation
of osteoblasts better than homopolymers. The present
study extends those observations and demonstrates
that there is a further advantage for HAP–polymer to
support the proliferation of osteoblasts. Other authors
have already proposed HAP–PCL composites for bone
engineering. For instance, Choi et al. (2004) prepared a
HAP–PCL composite using a synthetic apatite that was
included at 10–40 wt% in the polymer. This material
was suggested to be suitable as a bone substitute
scaffold, although the authors did not investigate its
biocompatibility/osteoinduction properties. In addition,
Kim et al. (2004) developed a HAP–PCL composite porous
bone scaffold for drug delivery. Recently Scaglione et al.
(2009) designed and developed a 3D osteoconductive
polymeric-based wide-net mesh using PCL and HAP.
They showed that the scaffolds displayed preferential cell
adhesion to the fibres with HAP in comparison with the
pure PCL fibre, as well as better in vivo bone ingrowth and
blood vessel colonization. Thus, our present composite
has the advantage of using a previously characterized
polymer (PCL) as well as PDIPF. This polyfumarate is a
more brittle material with a high tensile strength which,
when compatibilized with PCL, gives rise to a material
with better mechanical properties. The addition of HAP
to the Blend further improves its mechanical properties
and osteoinductive capability, strengthening its use as a
substrate for hard tissue replacement.
Our present results also show that HAP–Blend
improved the surface available for osteoblastic differ-
entiation, mineralization and expression of osteogenic
transcription factors, which are crucial for bone forma-
tion. Since the scaffold material contains Ca/P–apatite,
it was not possible to evaluate mineralization (Ca/P
deposition) into the matrix by classic techniques such
as Sirius red S (for Ca) or von Kossa (for P) staining.
Thus, we evaluated the expression of Runx-2, one of the
major transcription factors expressed during osteogene-
sis. After 3 weeks (mineralization period) of culture in an
osteogenic medium, the pre-osteoblastic MC3T3E1 cell
line was committed to differentiate and mineralize the
matrix, and Runx-2 was expressed strongly when cells
were grown on HAP–polymer scaffolds.
5. Conclusions
We synthesized a novel scaffold, a PCL–PDIPF blend
incorporating hydroxyapatite composite (HAP–Blend),
a material with uniform dispersion of semi-nano HAP
particles and good interphase compatibility. The physical,
mechanical and biological properties of the scaffold
were compared with those of a Blend and PCL without
apatite. The inclusion of HAP substantially improves the
mechanical properties of the Blend. The in vitro cell
culture experiments suggest that the new HAP–Blend was
more osteogenic than the blend or PCL scaffolds. Together
the results suggest that the developed HAP–Blend
composite may potentially be used in bone tissue-
engineering applications.
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